LabCompass

Jennifer A. Woyach

Medicine · The Ohio State University

Early career · publishing since 2019Rising activity

Publications

10

Citations

62

Est. group size

~1

Recurring co-author estimate

Active years

7

Publishing since 2019

Research summary
AI-generated

Jennifer A. Woyach's research focuses on chronic lymphocytic leukemia (CLL) and related blood cancers, particularly the use of drugs called Bruton's Tyrosine Kinase (BTK) inhibitors, which block a protein that helps cancerous white blood cells survive and grow. Much of the work involves clinical trials testing these drugs alone or in combination with other therapies like venetoclax, as well as training programs to help doctors use these treatments effectively.

Chronic lymphocytic leukemia (CLL) treatmentBruton's Tyrosine Kinase (BTK) inhibitorsClinical trials for blood cancersCombination drug therapiesPhysician education on cancer treatment

Publication activity was minimal or absent for most of the past decade but increased sharply in 2024, suggesting a recent surge in research output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.8/year recently
17182019: 1 publication19202122232024: 7 publications7242025: 2 publications2526
Publishes in
  • Blood×3
  • Clinical Lymphoma Myeloma & Leukemia×2
  • Targeted Oncology×1
  • Haematologica×1
  • Hematology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile